Overview

Safety and Efficacy of Ferriprox™ (Deferiprone) Oral Solution in Iron Overloaded Pediatric Patients

Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
- The primary objective is to assess the safety of Ferriprox oral solution for the treatment of iron overload in pediatric patients with transfusion-dependent anemia. - The secondary objective is to assess the efficacy of Ferriprox oral solution in reducing iron overload in pediatric patients with transfusion-dependent anemia.
Phase:
Phase 3
Details
Lead Sponsor:
ApoPharma
Treatments:
Deferiprone
Pharmaceutical Solutions